Search results for: COVID-19 Research
Filter search results
The commercial case for investing in ALS
13 November 2025
…not fully considered. Opportunities for strategic investment: Rapid growth in ALS research, advances in AI and gene therapy, orphan drug incentives, and limited competition create strong potential for high-value investment…
How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.
26 March 2020
This presentation to the Australian Society for Antimicrobials (ASA) meeting in Melbourne, on 27th February 2020 draws on OHE research, funded by the Wellcome Trust, on adapting HTA methods and…
Progress in Mental Health
1 July 1966
…£30,000 a year-but this represents only one-tenth of what is given for cancer research. The pharmaceutical firms allocate a creditable proportion of their revenue to research. But, whatever the total…
Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA
17 January 2024
…recent decades to drive conversations around the interactions between health, health systems and the environment. Jens also presented original research suggesting that payers expect the likelihood of sustainability playing a…
The Influence of Cost-effectiveness and Other Factors on NICE Decisions
1 November 2013
In this Research Paper, the authors explore which factors have most influenced NICE decisions from 1999 through the end of 2011. The research has two objectives: identifying the influence of…
Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold
12 January 2013
…Sculpher, M. (2013) Methods for the estimation of the NICE cost effectiveness threshold. CHE Research Paper 81. Revised report following referees’ comments. York: Centre for Health Economics, University of York….
OHE is Pleased to Announce the Appointment Two New Economists: Marina Rodes Sanchez and Chris Sampson
12 October 2017
…disease, which has facilitated a variety of methodological and applied research in trial-based cost-effectiveness analysis, meta-analysis, decision analytic modelling, and studies using large data sets. Chris’s research interests include the…
What NHS Trusts Can Do to Reduce Waiting Times for Cancer Treatment
2 January 2020
…to implement changes to help improve both quality and efficiency. Recent research by the Economics team intended to support this has included research on A&E performance, NHS staffing, and inpatient…
NICE Decisions: Cost-effectiveness is the Most Significant Predictor
21 November 2013
…actually affect NICE decisions, then, is important. Just released is a new OHE Research Paper that explores which factors have most influenced NICE decisions through the end of 2011. The…